Lianyungang Jinkang Pharmaceutical Technology Co., Ltd. was founded in June 2002, with the registered capital of 30 million Yuan RMB. It is situated in Industrial Park, Jinshan Town, Ganyu County, Lianyungang City, Jiangsu. The company occupies an area of more than 100 mu, with the building area of over 15,000 sq. m. For more than 10 years’ effort, the company now has advanced and professional workshops for gemcitabine, calcium levomefolate, calcium folinatc, magnesium tert-butoxide and other products. In 2006, the company invested 6 million Yuan RMB in establishing technology R&D center for the R&D of pharmaceutical intermediates and APIs in terms of anti-infection, anti-tumor, anti-AIDS, and so forth. Moreover, the company invested more than 10 million Yuan RMB to establish municipal technological research and development center of Lianyungang and synthetic technique engineering center of new fluoroquinolones drugs in Jiangsu. The company takes cooperation with universities, colleges and scientific research institutions seriously, and it has introduced dozens of professional and technical personnel from home and abroad. At present, the company has applied for more than 30 international and domestic patents, among which the (S,S)-2,8-Diazabicyclo[4,3,0]Nonane authorized patent was evaluated as one of the top-100 excellent patents by American Chemical Society, and in 2012, it was evaluated as one of the high-quality invention patents by Jiangsu Province. The company has more than 10 high-tech products of China and Jiangsu, new crystal L-5-Methyltetrahydrofolate calcium was evaluated as key and new product of Jiangsu Province. The company has won several honorary titles as Small and Medium-sized Technology-based Enterprise of Jiangsu Province, High-tech Enterprise, and so forth. Furthermore, the company has got the fund support from Ministry of Science and Technology and from Jiangsu Key Scientific and Technological Achievement Project. In 2011, the company established its wholly-owned subsidiary Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. in Lianyungang Economic and Technological Development Zone, and established 5 API GMP production lines. These actions accelerate the pace towards standardized market at home and abroad. Based on the purpose of "Quality first, integrity top, harmonious development, caring for health", we are highly praised and trusted by friends and clients at home and abroad. "Standard management, technological innovation" is the fundamental force and eternal source for Company’s scientific development. Over the years, the company has conscientiously performed its duties, participated in charitable causes, thus it has won several honorary titles like Excellent Private Enterprise of Lianyungang City, Star Enterprise of Ganyu County, grade A Tax-paying Credit Enterprise of Lianyungang City, the Fourth Entrepreneurship Star of Jiangsu, etc.

Registered Capital:  30 million

Registered Address:  Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu, 222115, P.R.China.

Company Type:  MPR

Business Scope:  Pharmaceutical technology research and development; APIs (limited to gemcitabine hydrochloride, D-cysteine hydrochloride monohydrate, calcium folinate, calcium 6S-5-methyltetrahydrofolate, mesna, abacavir, Production of intermediates for fitinib, capecitabine, moxifloxacin, pemifloxacin disodium, gemifloxacin, lamivudine, ritonavir); food additives (6S-5-methyltetrahydrofolate) Calcium) production; self-operated and agency import and export business of various commodities and technologies, excep